Genomic Grade Index (GGI): Feasibility in Routine Practice and Impact on Treatment Decisions in Early Breast Cancer

计划入组 180 人 · 首次发布于 2013 年 8 月 6 日

Efficacy of Imatinib in Patients With Intermediate-risk Gastrointestinal Stromal Tumor With a High-risk Genomic Grade Index

计划入组 80 人 · 首次发布于 2015 年 10 月 15 日

GRADE-SRM: Genomic Risk Assessment and Decisional Evaluation for Small Renal Masses

计划入组 265 人 · 首次发布于 2019 年 1 月 28 日

FLAMOD

Stimulan-VG

Escozine

GENOMIC HEALTH, INC.

United States

Genomic Prediction, Inc.

United States

INDEX PHARMACEUTICALS

India

ASTER 70 Trial Shows No Survival Benefit from Adjuvant Chemotherapy in Elderly Breast Cancer Patients

Cardiol Therapeutics Added to PRISM Emerging Biotech Index

pGTI Applied in STAR-JIA Trial to Assess Steroid Toxicity in Children with Juvenile Idiopathic Arthritis